125
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Transcriptional responses associated with sulfur mustard and thermal burns in porcine skin

, , , &
Pages 135-160 | Published online: 19 Nov 2008

References

  • AM Bowcock, W Shannon, F Du, J Duncan, K Cao, K Aftergut, J Catier, MA Fernandez-Vina, and A Menter. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 2001; 10:1793–1805.
  • J Cole, R Tsou, K Wallace, N Gibran, and F Isik. Comparison of normal human skin gene expression using cDNA microarrays. Wound Repair Regen 2001; 9:77–85.
  • EV Curto, GW Lambert, RL Davis, TW Wilborn, and TP Dooley. Biomarkers of human skin cells identified using DermArray DNA arrays and new bioinformatics methods. Biochem Biophys Res Commun 2002; 291:1052–1064.
  • JN McDougal, CM Garrett, CM Amato, and SJ Berberich. Effects of brief cutaneous JP-8 jet fuel exposures on time course of gene expression in the epidermis. Toxicol Sci 2007; 95:495–510.
  • JN McDougal, and CM Garrett. Gene expression and target tissue dose in the rat epidermis after brief JP-8 and JP-8 aromatic and aliphatic component exposures. Toxicol Sci 2007; 97:569–581.
  • JL Oestreicher, IB Walters, T Kikuchi, P Gilleaudeau, J Surette, U Schwertschlag, AJ Dorner, JG Krueger, and WL Trepicchio. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 2001; 1:272–287.
  • JV Rogers, CM Garrett, and JN McDougal. Gene expression in rat skin induced by irritating chemicals. J Biochem Mol Toxicol 2003; 17:123–137.
  • JV Rogers, YW Choi, RC Kiser, MC Babin, RP Casillas, JJ Schlager, and CL Sabourin. Microarray analysis of gene expression in murine skin exposed to sulfur mustard. J Biochem Mol Toxicol 2004; 18:289–299.
  • A Sesto, M Navarro, F Burslem, and JL Jorcano. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA 2002; 99:2965–2970.
  • AK Smiley, JM Klingenberg, BJ Aronow, ST Boyce, WJ Kitzmiller, and DM Supp. Microarray analysis of gene expression in cultured skin substitutes compared with native human skin. J Invest Dermatol 2005; 125:1286–1301.
  • J Takao, K Ariizumi, II Dougherty, and PD CruzJr. Genomic scale analysis of the human keratinocyte response to broad-band ultraviolet-B irradiation. Photodermatol Photoimmunol Photomed 2002; 18:5–13.
  • Z Wang, Y Liu, M Mori, and M Kulesz-Martin. Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates. Carcinogenesis 2002; 23:635–643.
  • Z Goldberg, DM Rocke, C Schwietert, SR Berglund, A Santana, A Jones, J Lehmann, R Stern, R Lu, and SC Hartmann. Human in vivo dose-response to controlled, low-dose low linear energy transfer ionizing radiation exposure. Clin Cancer Res 2006; 12:3723–3729.
  • III Dillman JF, AI Hege, CS Phillips, LD Orzolek, AJ Sylvester, C Bossone, C Henemyre-Harris, RC Kiser, YW Choi, JJ Schlager, and CL Sabourin. Microarray analysis of mouse ear tissue exposed to bis-(2-chloroethyl) sulfide: gene expression profiles correlate with treatment efficacy and an established clinical endpoint. J Pharmacol Exp Ther 2006; 317:76–87.
  • PL Platteborze. Effects of sulfur mustard on transcription in human epidermal keratinocytes: analysis by mRNA differential display. J Appl Toxicol 2003; 23:249–254.
  • CL Sabourin, JP Petrali, and RP Casillas. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin. J Biochem Mol Toxicol 2000; 14:291–302.
  • CL Sabourin, MM Danne, KL Buxton, RP Casillas, and JJ Schlager. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 2002; 16:263–272.
  • CL Sabourin, MM Danne, KL Buxton, JV Rogers, NA Niemuth, JA Blank, MC Babin, and RP Casillas. Modulation of sulfur mustard-induced inflammation and gene expression by olvanil in the hairless mouse vesicant model. J Cutan Ocular Toxicol 2003; 22:125–136.
  • CL Sabourin, JV Rogers, MK Stonerock, NA Niemuth, RC Kiser, SL Casbohm, MC Babin, JJ Schlager, and RP Casillas. Alterations of gene expression in sulfur mustard-exposed skin topically-treated with vanilloids. J Cutan Ocular Toxicol 2004; 23:321–328.
  • JJ Schlager, and BW Hart. Stress gene activity in HepG2 cells after sulfur mustard exposure. J Appl Toxicol 2000; 20:395–405.
  • RJ Feezor, HN Paddock, HV Baker, JC Varela, J Barreda, LL Moldawer, GS Schultz, and DW Mozingo. Temporal patterns of gene expression in murine cutaneous burn wound healing. Physiol Genomics 2004; 16:341–348.
  • M Spies, MR Dasu, N Svrakic, O Nesic, RE Barrow, JR Perez-Polo, and DN Herndon. Gene expression analysis in burn wounds of rats. Am J Physiol Regul Integr Comp Physiol 2002; 283:R918–R930.
  • IP Dick, and RC Scott. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol 1992; 44:640–645.
  • PA Hebda, CK Klingbeil, JA Abraham, and JC Fiddes. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 1990; 95:626–631.
  • W Montagna, and JS Yun. The skin of the domestic pig. J Invest Dermatol 1964; 42:11–21.
  • KJ Smith, R Casillas, J Graham, HG Skelton, F Stemler, and BE HackleyJr. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. J Dermatol Sci 1997; 14:126–135.
  • JS Graham, KT Schomacker, RD Glatter, CM Briscoe, EH BraueJr, and KS Squibb. Efficacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns 2002; 28:719–730.
  • FM Reid, J Graham, NA Niemuth, AW Singer, SJ Janny, and JB Johnson. Sulfur mustard-induced skin burns in weanling swine evaluated clinically and histopathologically. J Appl Toxicol 2000; 20 (Suppl 1):S153–S160.
  • JS Graham, KT Schomacker, RD Glatter, CM Briscoe, EH BraueJr, and KS Squibb. Bioengineering methods employed in the study of wound healing of sulphur mustard burns. Skin Res Technol 2002; 8:57–69.
  • JS Graham, FM Reid, NA Niemuth, SM Shumaker, and JD Waugh. Effects of three anesthetic regimens on bioengineering methods conducted on ventral abdominal skin of weanling swine. J Cutan Ocular Toxicol 2004; 23:105–118.
  • P Rice, RF Brown, DG Lam, RP Chilcott, and NJ Bennett. Dermabrasion—a novel concept in the surgical management of sulphur mustard injuries. Burns 2000; 26:34–40.
  • JS Graham, FM Reid, JR Smith, RR Stotts, ES Tucker, SM Shumaker, NA Niemuth, and SJ Janny. A cutaneous full-thickness liquid sulfur mustard burn model in weanling swine: clinical pathology and urinary excretion of thiodiglycol. J Appl Toxicol 2000; 20 (Suppl 1):S161–S172.
  • JS Graham, RS Stevenson, LW Mitcheltree, M Simon, TA Hamilton, RR Deckert, and RB Lee. Improved wound healing of cutaneous sulfur mustard injuries in a weanling pig model. J Burns Wounds 2006; 5:e7.
  • S Tsai, JP Cassady, BA Freking, DJ Nonneman, GA Rohrer, and JA Piedrahita. Annotation of the Affymetrix porcine genome microarray. Anim Genet 2006; 37:423–424.
  • MR Dasu, HK Hawkins, RE Barrow, H Xue, and DN Herndon. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J Pathol 2004; 202:476–485.
  • HN Paddock, GS Schultz, HV Baker, JC Varela, EA Beierle, LL Moldawer, and DW Mozingo. Analysis of gene expression patterns in human postburn hypertrophic scars. J Burn Care Rehabil 2003; 24:371–377.
  • R Tsou, JK Cole, AB Nathens, FF Isik, DM Heimbach, LH Engrav, and NS Gibran. Analysis of hypertrophic and normal scar gene expression with cDNA microarrays. J Burn Care Rehabil 2000; 21:541–550.
  • J Wu, B Ma, S Yi, Z Wang, W He, G Luo, X Chen, X Wang, A Chen, and D Barisoni. Gene expression of early hypertrophic scar tissue screened by means of cDNA microarrays. J Trauma 2004; 57:1276–1286.
  • JS Graham, RP Chilcott, P Rice, SM Milner, CG Hurst, and BI Maliner. Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J Burns Wounds 2005; 4:e1.
  • S Ray, M Britschgi, C Herbert, Y Takeda-Uchimura, A Boxer, K Blennow, LF Friedman, DR Galasko, M Jutel, A Karydas, JA Kaye, J Leszek, BL Miller, L Minthon, JF Quinn, GD Rabinovici, WH Robinson, MN Sabbagh, YT So, DL Sparks, M Tabaton, J Tinklenberg, JA Yesavage, R Tibshirani, and T Wyss-Coray. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007; 13:1359–1362.
  • JB Holcomb. The 2004 Fitts lecture: current perspective on combat casualty care. J Trauma 2005; 59:990–1002.
  • BW Starnes, AC Beekley, JA Sebesta, CA Andersen, and RM RushJr. Extremity vascular injuries on the battlefield: tips for surgeons deploying to war. J Trauma 2006; 60:432–442.
  • W Xiao-Wu, DN Herndon, M Spies, AP Sanford, and SE Wolf. Effects of delayed wound excision and grafting in severely burned children. Arch Surg 2002; 137:1049–1054.
  • S Enoch, JE Grey, and KG Harding. ABC of wound healing. Non-surgical and drug treatments. BMJ 2006; 332:900–903.
  • LA DiPietro. Wound healing: the role of the macrophage and other immune cells. Shock 1995; 4:233–240.
  • R Gillitzer, and M Goebeler. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69:513–521.
  • S Werner, and R Grose. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83:835–870.
  • S Bhat, YH Song, C Lawyer, and SM Milner. Modulation of the complement system by human beta-defensin 2. J Burns Wounds 2007; 5:e10.
  • F Suber, MC Carroll, and FD MooreJr. Innate response to self-antigen significantly exacerbates burn wound depth. Proc Natl Acad Sci USA 2007; 104:3973–3977.
  • SS Asghar, and MC Pasch. Therapeutic inhibition of the complement system. Y2K update. Front Biosci 2000; 5:E63–E81.
  • SC Makrides. Therapeutic inhibition of the complement system. Pharmacol Rev 1998; 50:59–87.
  • C Caliezi, WA Wuillemin, S Zeerleder, M Redondo, B Eisele, and CE Hack. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 2000; 52:91–112.
  • LR Lund, KA Green, AA Stoop, M Ploug, K Almholt, J Lilla, BS Nielsen, IJ Christensen, CS Craik, Z Werb, K Dano, and J Romer. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J 2006; 25:2686–2697.
  • F Maquerlot, S Galiacy, M Malo, C Guignabert, DA Lawrence, MP d'Ortho, and G Barlovatz-Meimon. Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing. Am J Pathol 2006; 169:1624–1632.
  • M Watanabe, W Yano, S Kondo, Y Hattori, N Yamada, R Yanai, and T Nishida. Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. Invest Ophthalmol Vis Sci 2003; 44:3332–3338.
  • N Okumura, T Seki, and T Ariga. Cell surface-bound plasminogen regulates hepatocyte proliferation through a uPA-dependent mechanism. Biosci Biotechnol Biochem 2007; 71:1542–1549.
  • Y Yamaguchi, K Yamada, T Suzuki, YP Wu, K Kita, S Takahashi, M Ichinose, and N Suzuki. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP). Am J Physiol Endocrinol Metab 2004; 287:E970–E976.
  • N Borregaard, K Theilgaard-Monch, JB Cowland, M Stahle, and OE Sorensen. Neutrophils and keratinocytes in innate immunity—cooperative actions to provide antimicrobial defense at the right time and place. J Leukoc Biol 2005; 77:439–443.
  • JD van Buul, and PL Hordijk. Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 2004; 24:824–833.
  • NS Gibran, M Ferguson, DM Heimbach, and FF Isik. Monocyte chemoattractant protein-1 mRNA expression in the human burn wound. J Surg Res 1997; 70:1–6.
  • ME Swift, AL Burns, KL Gray, and LA DiPietro. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 2001; 117:1027–1035.
  • KS Weber, PJ Nelson, HJ Grone, and C Weber. Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 1999; 19:2085–2093.
  • J Tsuruta, K Sugisaki, AM DannenbergJr, T Yoshimura, Y Abe, and P Mounts. The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 1996; 20:293–318.
  • RB Goodman, JW Forstrom, SG Osborn, EY Chi, and TR Martin. Identification of two neutrophil chemotactic peptides produced by porcine alveolar macrophages. J Biol Chem 1991; 266:8455–8463.
  • R Schramm, Q Liu, and H Thorlacius. Expression and function of MIP-2 are reduced by dexamethasone treatment in vivo. Br J Pharmacol 2000; 131:328–334.
  • SD Wolpe, and A Cerami. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J 1989; 3:2565–2573.
  • TN Ledger, P Pinton, D Bourges, P Roumi, H Salmon, and IP Oswald. Development of a macroarray to specifically analyze immunological gene expression in swine. Clin Diagn Lab Immunol 2004; 11:691–698.
  • Y Fang, SJ Gong, YH Xu, BD Hambly, and S Bao. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice. Br J Dermatol 2007; 157:458–465.
  • A Schaffner, P Rhyn, G Schoedon, and DJ Schaer. Regulated expression of platelet factor 4 in human monocytes—role of PARs as a quantitatively important monocyte activation pathway. J Leukoc Biol 2005; 78:202–209.
  • S Frank, H Kampfer, C Wetzler, B Stallmeyer, and J Pfeilschifter. Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem J 2000; 347 (pt 1):265–273.
  • G Yu, AH Rux, P Ma, K Bdeir, and BS Sachais. Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. Blood 2005; 105:3545–3551.
  • S Avniel, Z Arik, A Maly, A Sagie, HB Basst, MD Yahana, ID Weiss, B Pal, O Wald, D Ad-El, N Fujii, F Renzana-Seisdedos, S Jung, E Galun, E Gur, and A Peled. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol 2006; 126:468–476.
  • L Florin, N Maas-Szabowski, S Werner, A Szabowski, and P Angel. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts. J Cell Sci 2005; 118:1981–1989.
  • T Peters, A Sindrilaru, B Hinz, R Hinrichs, A Menke, EA Al-Azzeh, K Holzwarth, T Oreshkova, H Wang, D Kess, B Walzog, S Sulyok, C Sunderkotter, W Friedrich, M Wlaschek, T Krieg, and K Scharffetter-Kochanek. Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J 2005; 24:3400–3410.
  • SR Edmondson, SP Thumiger, GA Werther, and CJ Wraight. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev 2003; 24:737–764.
  • KW Moore, MR de Waal, RL Coffman, and A O'Garra. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683–765.
  • SA Eming, S Werner, P Bugnon, C Wickenhauser, L Siewe, O Utermohlen, JM Davidson, T Krieg, and A Roers. Accelerated wound closure in mice deficient for interleukin-10. Am J Pathol 2007; 170:188–202.
  • A Moroguchi, K Ishimura, K Okano, H Wakabayashi, T Maeba, and H Maeta. Interleukin-10 suppresses proliferation and remodeling of extracellular matrix of cultured human skin fibroblasts. Eur Surg Res 2004; 36:39–44.
  • S Alas, and B Bonavida. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res 2001; 61:5137–5144.
  • RL Chelvarajan, Y Liu, D Popa, ML Getchell, TV Getchell, AJ Stromberg, and S Bondada. Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol 2006; 79:1314–1327.
  • H Cheon, YH Rho, SJ Choi, YH Lee, GG Song, J Sohn, NH Won, and JD Ji. Prostaglandin E2 augments IL-10 signaling and function. J Immunol 2006; 177:1092–1100.
  • Y Kalechman, B Sredni, T Weinstein, I Freidkin, A Tobar, M Albeck, and U Gafter. Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101. J Am Soc Nephrol 2003; 14:620–630.
  • JT Mao, MD Roth, KJ Serio, F Baratelli, L Zhu, EC Holmes, RM Strieter, and SM Dubinett. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers. Clin Cancer Res 2003; 9:5835–5841.
  • TS Lee, and LY Chau. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002; 8:240–246.
  • M Hallman, M Ramet, and RA Ezekowitz. Toll-like receptors as sensors of pathogens. Pediatr Res 2001; 50:315–321.
  • S Janssens, and R Beyaert. Role of toll-like receptors in pathogen recognition. Clin Microbiol Rev 2003; 16:637–646.
  • D Werling, and TW Jungi. TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol 2003; 91:1–12.
  • JW Breslin, MH Wu, M Guo, R Reynoso, and SY Yuan. Toll-like receptor 4 contributes to microvascular inflammation and barrier dysfunction in thermal injury. Shock 2008; 29:349–355.
  • JE McInturff, RL Modlin, and J Kim. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 2005; 125:1–8.
  • R Badolato. Leukocyte circulation: one-way or round-trip? Lessons from primary immunodeficiency patients. J Leukoc Biol 2004; 76:1–6.
  • SA Kellermann, S Hudak, ER Oldham, YJ Liu, and LM McEvoy. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol 1999; 162:3859–3864.
  • DF Robbiani, RA Finch, D Jager, WA Muller, AC Sartorelli, and GJ Randolph. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000; 103:757–768.
  • MC Babin, K Ricketts, JP Skvorak, M Gazaway, LW Mitcheltree, and RP Casillas. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J Appl Toxicol 2000; 20 (Suppl 1):S141–S144.
  • RP Casillas, RC Kiser, JA Truxall, AW Singer, SM Shumaker, NA Niemuth, KM Ricketts, LW Mitcheltree, LR Castrejon, and JA Blank. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J Appl Toxicol 2000; 20 (Suppl 1):S145–S151.
  • U Wormser, B Brodsky, BS Green, R Rad-Yellin, and A Nyska. Protective effect of povidone-iodine ointment against skin lesions induced by sulphur and nitrogen mustards and by non-mustard vesicants. Arch Toxicol 1997; 71:165–170.
  • CH Lang, C Silvis, G Nystrom, and RA Frost. Regulation of myostatin by glucocorticoids after thermal injury. FASEB J 2001; 15:1807–1809.
  • A Khan, J Greenman, and SJ Archibald. Small molecule CXCR4 chemokine receptor antagonists: developing drug candidates. Curr Med Chem 2007; 14:2257–2277.
  • L Tan, N Hatzirodos, and PJ Wormald. Effect of nerve growth factor and keratinocyte growth factor on wound healing of the sinus mucosa. Wound Repair Regen 2007.;
  • K Inoue, T Takahashi, K Uehara, H Shimuzu, K Ido, H Morimatsu, E Omori, H Katayama, R Akagi, and K Morita. Protective role of heme oxygenase 1 in the intestinal tissue injury In hemorrhagic shock in rats. Shock 2008; 29:252–261.
  • J Yamada, MR Dana, C Sotozono, and S Kinoshita. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res 2003; 76:161–167.
  • M Ii, N Matsunaga, K Hazeki, K Nakamura, K Takashima, T Seya, O Hazeki, T Kitazaki, and Y Iizawa. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol Pharmacol 2006; 69:1288–1295.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.